Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Wonderlab Nicotinamide Drink
Chongqing Precision Biotech Co., Ltd
Skin Darken
1 trial -
Xiangsha Liujunzi granules
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Functional Dyspepsia
1 trial -
Yinxingmihuan oral solution
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Chronic Stable Angina
1 trial -
YishenShujin Decoction
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Fibromyalgia Syndrome
1 trial -
active nicotine gum
BRIGHT MINDS BIOSCIENCES INC.
Smoking
1 trial -
active tDCS and cognitive training intervention
United Therapeutics Europe Ltd
Brain Concussion
2 trials -
atosiban
Hospital Authority, Hong Kong
Repeated Implantation Failure
1 trial -
bismuth-containing quadral therapy based on antibiotic susceptibility
Shandong University
Helicobacter Pylori
1 trial -
blood draw from three different vessels
Sionna Therapeutics
Accidental Hypothermia
1 trial -
bovine Lactoferrin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Nosocomial Infections
1 trial -
buprenorphine and low-dose naloxone
Indivior Pty Ltd
Pain
1 trial -
calcitriol
Ultragenyx UK Limited
Psoriasis
1 trial -
cefditoren pivoxil tablets
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Medication Safety
1 trial -
chemotherapy
United Therapeutics Europe Ltd
Malignant Mesothelioma
1 trial -
cipher prescription 1
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Percutaneous Coronary Artery Intervention
1 trial -
cocaine
BRIGHT MINDS BIOSCIENCES INC.
Cocaine Dependence
1 trial -
conventional radiotherapy 74 Gy delivered in 37 fractions
United Therapeutics Europe Ltd
Prostate Cancer
1 trial -
dexmedetomidine
Sana Biotechnology
Laparoscopic Cholecystectomy
1 trial -
drug
The First People's Hospital of Lianyungang
Hypertension
1 trial -
estradiol plus progesterone 100 mg IM injection
Universal Integrated
IVF
1 trial -
extended release niacin
United Therapeutics Europe Ltd
HIV Infections
1 trial -
fMRI
BRIGHT MINDS BIOSCIENCES INC.
Substance Use
1 trial -
fecal microbiota transplantation
The First People's Hospital of Lianyungang
Fecal Microbiota Transplantation
1 trial -
foundational treatment
The First People's Hospital of Lianyungang
Acute Ischemic Stroke
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources